SenoRx Expands Breast Cancer Business Beyond Biopsies To Disease Therapy
This article was originally published in The Gray Sheet
Executive Summary
SenoRx plans to submit a 510(k) application to FDA in the second half of this year for its Radiation Balloon catheter system for breast cancer treatment